Condensed Consolidated Statements of Stockholders Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 321,084	$ 4	$ 417,363	$ (388)	$ (95,895)
Beginning balance, shares at Dec. 31, 2021		37,379,077
Issuance of common stock upon exercise of common stock options	210		210
Issuance of common stock upon exercise of common stock options, shares		244,981
Stock-based compensation	2,731		2,731
Unrealized (loss) gain on available-for-sale securities	(1,068)			(1,068)
Net loss	(20,980)				(20,980)
Ending balance at Mar. 31, 2022	301,977	$ 4	420,304	(1,456)	(116,875)
Ending balance, shares at Mar. 31, 2022		37,624,058
Beginning balance at Dec. 31, 2021	321,084	$ 4	417,363	(388)	(95,895)
Beginning balance, shares at Dec. 31, 2021		37,379,077
Unrealized (loss) gain on available-for-sale securities	(2,084)
Net loss	(65,504)
Ending balance at Sep. 30, 2022	262,249	$ 4	426,116	(2,472)	(161,399)
Ending balance, shares at Sep. 30, 2022		37,817,724
Beginning balance at Mar. 31, 2022	301,977	$ 4	420,304	(1,456)	(116,875)
Beginning balance, shares at Mar. 31, 2022		37,624,058
Issuance of common stock upon exercise of common stock options	83		83
Issuance of common stock upon exercise of common stock options, shares		163,387
Issuance of common stock under employee stock purchase plan	214		214
Issuance of common stock under employee stock purchase plan, shares		30,279
Stock-based compensation	3,095		3,095
Unrealized (loss) gain on available-for-sale securities	(469)			(469)
Net loss	(24,335)				(24,335)
Ending balance at Jun. 30, 2022	280,565	$ 4	423,696	(1,925)	(141,210)
Ending balance, shares at Jun. 30, 2022		37,817,724
Stock-based compensation	2,420		2,420
Unrealized (loss) gain on available-for-sale securities	(547)			(547)
Net loss	(20,189)				(20,189)
Ending balance at Sep. 30, 2022	262,249	$ 4	426,116	(2,472)	(161,399)
Ending balance, shares at Sep. 30, 2022		37,817,724
Beginning balance at Dec. 31, 2022	235,137	$ 4	428,623	(1,956)	(191,534)
Beginning balance, shares at Dec. 31, 2022		37,877,387
Issuance of common stock upon exercise of common stock options	99		99
Issuance of common stock upon exercise of common stock options, shares		73,213
Stock-based compensation	2,782		2,782
Unrealized (loss) gain on available-for-sale securities	927			927
Net loss	(27,820)				(27,820)
Ending balance at Mar. 31, 2023	211,125	$ 4	431,504	(1,029)	(219,354)
Ending balance, shares at Mar. 31, 2023		37,950,600
Beginning balance at Dec. 31, 2022	$ 235,137	$ 4	428,623	(1,956)	(191,534)
Beginning balance, shares at Dec. 31, 2022		37,877,387
Issuance of common stock upon exercise of common stock options, shares	81,095
Unrealized (loss) gain on available-for-sale securities	$ 1,278
Net loss	(90,387)
Ending balance at Sep. 30, 2023	154,764	$ 4	437,359	(678)	(281,921)
Ending balance, shares at Sep. 30, 2023		38,054,583
Beginning balance at Mar. 31, 2023	211,125	$ 4	431,504	(1,029)	(219,354)
Beginning balance, shares at Mar. 31, 2023		37,950,600
Issuance of common stock upon exercise of common stock options	11		11
Issuance of common stock upon exercise of common stock options, shares		7,882
Issuance of common stock under employee stock purchase plan	231		231
Issuance of common stock under employee stock purchase plan, shares		96,101
Stock-based compensation	3,119		3,119
Unrealized (loss) gain on available-for-sale securities	90			90
Net loss	(29,597)				(29,597)
Ending balance at Jun. 30, 2023	184,979	$ 4	434,865	(939)	(248,951)
Ending balance, shares at Jun. 30, 2023		38,054,583
Stock-based compensation	2,494		2,494
Unrealized (loss) gain on available-for-sale securities	261			261
Net loss	(32,970)				(32,970)
Ending balance at Sep. 30, 2023	$ 154,764	$ 4	$ 437,359	$ (678)	$ (281,921)
Ending balance, shares at Sep. 30, 2023		38,054,583